We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 407960

CAS#: 2070015-09-5

Description: NU6300 is a covalent, irreversible, ATP-Competitive CDK2 inhibitor with Ki of 6 nM.

Price and Availability

Size Price Shipping out time Quantity
Inquire bulk and customized quantity

Pricing updated 2020-08-08. Prices are subject to change without notice.

NU6300 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to to inquire quote.

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 407960
Name: NU6300
CAS#: 2070015-09-5
Chemical Formula: C20H23N5O3S
Exact Mass: 413.1522
Molecular Weight: 413.496
Elemental Analysis: C, 58.09; H, 5.61; N, 16.94; O, 11.61; S, 7.75

Synonym: NU6300; NU-6300; NU 6300;

IUPAC/Chemical Name: 6-(cyclohexylmethoxy)-N-(4-(vinylsulfonyl)phenyl)-9H-purin-2-amine


InChi Code: InChI=1S/C20H23N5O3S/c1-2-29(26,27)16-10-8-15(9-11-16)23-20-24-18-17(21-13-22-18)19(25-20)28-12-14-6-4-3-5-7-14/h2,8-11,13-14H,1,3-7,12H2,(H2,21,22,23,24,25)


Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:


1: Anscombe E, Meschini E, Mora-Vidal R, Martin MP, Staunton D, Geitmann M,
Danielson UH, Stanley WA, Wang LZ, Reuillon T, Golding BT, Cano C, Newell DR,
Noble ME, Wedge SR, Endicott JA, Griffin RJ. Identification and Characterization
of an Irreversible Inhibitor of CDK2. Chem Biol. 2015 Sep 17;22(9):1159-64. doi:
10.1016/j.chembiol.2015.07.018. Epub 2015 Aug 27. PubMed PMID: 26320860; PubMed
Central PMCID: PMC4579270.